首页> 外文期刊>Journal of Colloid and Interface Science >Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids
【24h】

Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids

机译:通过邻酯键制备的透明质酸纳米凝胶显示pH-触发的行为,在3-D肿瘤球状体中增强渗透和抗肿瘤功效

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A new type of pH-triggered hyaluronic acid nanogel system (HA-NGs) was successfully developed for tumor-targeted delivery of drugs. HA-NGs were obtained by copolymerization between methacrylate HA and a new cross-linker containing ortho ester groups in an aqueous solution. The therapeutic drug (DOX) was loaded into the HA-NGs (DOX@HA-NGs) and exhibited appropriate loading of about 17.3% with a size of around 200 nm. Such new pH-triggered HA-NGs are found to be highly desirable for targeted cancer therapy because it could significantly minimize the amount of premature drug release in neutral pH, and also provide a sufficient amount of drug to effectively kill the cancer cells caused by the degradation of ortho ester groups at acid pH values. Results from the cellular uptake and cytotoxicity of DOX@HA-NGs performed in two-dimensional (2D) cell culture demonstrated that DOX@HA-NGs exhibit excellent tumor homing and higher cytotoxicity. Importantly, the penetration and inhibition against three-dimensional (3D) tumor spheroids demonstrated that DOX@HA-NGs could fully penetrate into HepG2 tumor spheroids, thus leading to higher inhibition. So, such new tumor-targeting DOX@HA-NGs prepared via ortho ester linkages will exhibit excellent stability in a neutral environment, pH-triggered drug release, as well as enhanced penetration and destruction against 3D tumor spheroids, thereby making targeted cancer therapy possible. (C) 2017 Elsevier Inc. All rights reserved.
机译:成功开发了一种新型的pH-触发透明质酸纳米凝胶系统(HA-NGS),用于肿瘤靶向递送药物。通过在水溶液中的甲基丙烯酸酯HA和含有邻酯基的新交联剂之间的共聚合获得HA-NG。将治疗药物(DOX)加载到HA-NGS(DOX @ HA-NGS)中,并表现出约17.3%的适当负载,大小约为200nm。发现这种新的pH-触发的HA-NGs是针对靶向癌症治疗的非常希望的,因为它可以显着地最小化中性pH的过早药物释放量,并且还提供足够量的药物以有效杀死由此引起的癌细胞酸pH值下的邻酯基团的降解。由二维(2D)细胞培养中的DOX @ HA-NGS的细胞摄取和细胞毒性的结果证明了DOX @ HA-NGS表现出优异的肿瘤归巢和更高的细胞毒性。重要的是,对三维(3D)肿瘤球状体的渗透和抑制证明DOX @ HA-NGs可以完全渗透到HepG2肿瘤球状体中,从而导致更高的抑制作用。因此,通过Ortho酯键制备的这种新的肿瘤靶向DOX @ HA-NGS在中性环境中表现出优异的稳定性,pH触发的药物释放,以及增强对3D肿瘤球状体的渗透和破坏,从而使靶向癌症治疗成为可能。 (c)2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号